
Matthew John Kasztejna
Examiner (ID: 13619, Phone: (571)272-6086 , Office: P/3779 )
| Most Active Art Unit | 3779 |
| Art Unit(s) | 3795, 3779, 3739, 3993, 3799 |
| Total Applications | 1245 |
| Issued Applications | 699 |
| Pending Applications | 148 |
| Abandoned Applications | 418 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18732586
[patent_doc_number] => 11801306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Compositions and methods for targeted RNA delivery
[patent_app_type] => utility
[patent_app_number] => 17/533461
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 101173
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533461 | Compositions and methods for targeted RNA delivery | Nov 22, 2021 | Issued |
Array
(
[id] => 20341334
[patent_doc_number] => 12465048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Defoamer useful in a peracid composition with anionic surfactants
[patent_app_type] => utility
[patent_app_number] => 17/455563
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9677
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17455563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/455563 | Defoamer useful in a peracid composition with anionic surfactants | Nov 17, 2021 | Issued |
Array
(
[id] => 17441801
[patent_doc_number] => 20220062306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => COMPOUNDS FOR PRENATAL TREATMENT COMPRISIING A NATAL VITAMIN AND ASPIRIN AND METHOD FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/522548
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522548
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522548 | COMPOUNDS FOR PRENATAL TREATMENT COMPRISIING A NATAL VITAMIN AND ASPIRIN AND METHOD FOR MAKING AND USING THE SAME | Nov 8, 2021 | Abandoned |
Array
(
[id] => 17480695
[patent_doc_number] => 20220088199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION
[patent_app_type] => utility
[patent_app_number] => 17/520934
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520934 | METHOD FOR PROTECTING GLYCEROL ALKYL ETHERS FROM OXIDATION | Nov 7, 2021 | Abandoned |
Array
(
[id] => 18691054
[patent_doc_number] => 20230321247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITION FOR TREATING AND/OR PREVENTING FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/251929
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251929 | Composition for treating and/or preventing fungal infections | Nov 4, 2021 | Issued |
Array
(
[id] => 18859376
[patent_doc_number] => 20230413809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => DISINFECTANT COMPOSITION FOR SURFACES AND THE PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/252018
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252018
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252018 | DISINFECTANT COMPOSITION FOR SURFACES AND THE PREPARATION THEREOF | Nov 4, 2021 | Pending |
Array
(
[id] => 18806196
[patent_doc_number] => 20230380525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => NANOPARTICLES FOR USE IN ANTI PATHOGENIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/032493
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032493
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/032493 | NANOPARTICLES FOR USE IN ANTI PATHOGENIC APPLICATIONS | Oct 20, 2021 | Abandoned |
Array
(
[id] => 17503413
[patent_doc_number] => 20220096515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Methods and Formulations for Preventing Neurological or Psychiatric Disorders
[patent_app_type] => utility
[patent_app_number] => 17/488061
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488061
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488061 | Methods and Formulations for Preventing Neurological or Psychiatric Disorders | Sep 27, 2021 | Abandoned |
Array
(
[id] => 17334484
[patent_doc_number] => 20220000815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/479886
[patent_app_country] => US
[patent_app_date] => 2021-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17479886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/479886 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISORDERS | Sep 19, 2021 | Abandoned |
Array
(
[id] => 17702935
[patent_doc_number] => 20220202941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => LOW-BURST POLYMERS AND METHODS TO PRODUCE POLYMER
[patent_app_type] => utility
[patent_app_number] => 17/477361
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477361 | Low-burst polymers and methods to produce polymer | Sep 15, 2021 | Issued |
Array
(
[id] => 17768143
[patent_doc_number] => 11400061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Onychomycosis treatment compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/474656
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14728
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474656
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474656 | Onychomycosis treatment compositions and methods | Sep 13, 2021 | Issued |
Array
(
[id] => 18700018
[patent_doc_number] => 11786504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Taxane analogs for the treatment of brain cancer
[patent_app_type] => utility
[patent_app_number] => 17/470891
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 9
[patent_no_of_words] => 18819
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470891 | Taxane analogs for the treatment of brain cancer | Sep 8, 2021 | Issued |
Array
(
[id] => 17311916
[patent_doc_number] => 20210400964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => CHITOOLIGOSACCHARIDES AND METHODS FOR USE IN ENHANCING PLANT GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/467752
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467752 | Chitooligosaccharides and methods for use in enhancing plant growth | Sep 6, 2021 | Issued |
Array
(
[id] => 18535866
[patent_doc_number] => 20230240952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => USE, IN AQUEOUS-ALCOHOLIC COMPOSITIONS, OF A COPOLYMER OBTAINED BY PRECIPITATION POLYMERIZATION
[patent_app_type] => utility
[patent_app_number] => 18/044015
[patent_app_country] => US
[patent_app_date] => 2021-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044015
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044015 | USE, IN AQUEOUS-ALCOHOLIC COMPOSITIONS, OF A COPOLYMER OBTAINED BY PRECIPITATION POLYMERIZATION | Sep 5, 2021 | Abandoned |
Array
(
[id] => 19134602
[patent_doc_number] => 11969511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Methods and compositions for antimicrobial treatment
[patent_app_type] => utility
[patent_app_number] => 17/466189
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 38
[patent_no_of_words] => 19632
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466189 | Methods and compositions for antimicrobial treatment | Sep 2, 2021 | Issued |
Array
(
[id] => 19256826
[patent_doc_number] => 12016855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Prednisolone and moxifloxacin compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/458533
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70460
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458533 | Prednisolone and moxifloxacin compositions and methods | Aug 25, 2021 | Issued |
Array
(
[id] => 17525649
[patent_doc_number] => 11298315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Triamcinolone and moxifloxacin compositions
[patent_app_type] => utility
[patent_app_number] => 17/458523
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70192
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458523 | Triamcinolone and moxifloxacin compositions | Aug 25, 2021 | Issued |
Array
(
[id] => 18672957
[patent_doc_number] => 20230310412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => USE OF CASPASE INHIBITOR FOR ALLEVIATING OR TREATING OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 18/040496
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040496 | USE OF CASPASE INHIBITOR FOR ALLEVIATING OR TREATING OSTEOARTHRITIS | Aug 3, 2021 | Abandoned |
Array
(
[id] => 17398103
[patent_doc_number] => 20220040193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => FORMULATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/393196
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393196 | FORMULATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITORS | Aug 2, 2021 | Abandoned |
Array
(
[id] => 17397958
[patent_doc_number] => 20220040048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => DENTAL GLASS POWDER AND DENTAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/443542
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443542 | DENTAL GLASS POWDER AND DENTAL COMPOSITION | Jul 26, 2021 | Abandoned |